Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

James Breen

ID: 1b83d1fd-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

BYOOVIZ® (Ranibizumab-Nuna) Granted Interchangeable Status

Big Molecule Watch · November 10, 2023

Infliximab Clinical Trial Updates

Big Molecule Watch · August 12, 2022

Goodwin Actively Hiring Associates for IP Litigation Group

Big Molecule Watch · August 2, 2022

FDA Testimony Before the U.S. Senate Regarding Reauthorization of the Biosimilar User Fee Act

Big Molecule Watch · April 29, 2022

Coherus and Junshi Biosciences Announce FDA Acceptance of Toripalimab BLA

Big Molecule Watch · November 9, 2021

Previous

12

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog